Log on / register
Feedback | Support | My details
A consensus prognostic gene expression classifier for ER positive breast cancer.
Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C
Genome Biol 2006, 7:R101
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Elucidating the altered transcriptional programs in breast cancer using independent component analysis.
Teschendorff AE, Journée M, Absil PA, Sepulchre R, Caldas C
PLoS Comput Biol 2007 Aug, 3:e161
[PubMed Central] [PubMed] [Related articles]

2.
Module-based outcome prediction using breast cancer compendia.
van Vliet MH, Klijn CN, Wessels LF, Reinders MJ
PLoS One 2007, 2:e1047
[PubMed Central] [PubMed] [Related articles]

3.
ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.
Zou JX, Revenko AS, Li LB, Gemo AT, Chen HW
Proc Natl Acad Sci U S A 2007 Nov 13, 104:18067-72
[PubMed Central] [PubMed] [Related articles]

4.
Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.
Martin KJ, Patrick DR, Bissell MJ, Fournier MV
PLoS One 2008, 3:e2994
[PubMed Central] [PubMed] [Related articles]

5.
A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors.
Zhang J, Liu B, Jiang X, Zhao H, Fan M, Fan Z, Lee JJ, Jiang T, Jiang T, Song SW
PLoS One 2009, 4:e6274
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 16 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.